WallStSmart

Medical Properties Trust, Inc. (MPT)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 444% more annual revenue ($5.82B vs $1.07B). VTR leads profitability with a 4.3% profit margin vs -25.9%. MPT appears more attractively valued with a PEG of 1.61. MPT earns a higher WallStSmart Score of 57/100 (C).

MPT

Buy

57

out of 100

Grade: C

Growth: 4.7Profit: 4.5Value: 6.7Quality: 5.0

VTR

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 4.7Quality: 3.8
Piotroski: 4/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MPT.

VTRSignificantly Overvalued (-591.0%)

Margin of Safety

-591.0%

Fair Value

$12.40

Current Price

$82.70

$70.30 premium

UndervaluedFair: $12.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MPT3 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Operating MarginProfitability
65.6%10/10

Strong operational efficiency at 65.6%

Revenue GrowthGrowth
25.4%8/10

Revenue surging 25.4% year-over-year

VTR2 strengths · Avg: 8.0/10
Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

Areas to Watch

MPT4 concerns · Avg: 2.8/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-5.9%2/10

ROE of -5.9% — below average capital efficiency

Profit MarginProfitability
-25.9%1/10

Currently unprofitable

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : MPT

The strongest argument for MPT centers on Price/Book, Operating Margin, Revenue Growth. Revenue growth of 25.4% demonstrates continued momentum.

Bull Case : VTR

The strongest argument for VTR centers on Operating Margin, Revenue Growth. Revenue growth of 21.4% demonstrates continued momentum.

Bear Case : MPT

The primary concerns for MPT are PEG Ratio, EPS Growth, Return on Equity.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.2x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

MPT carries more volatility with a beta of 1.45 — expect wider price swings.

MPT is growing revenue faster at 25.4% — sustainability is the question.

VTR generates stronger free cash flow (368M), providing more financial flexibility.

Monitor REIT - HEALTHCARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MPT scores higher overall (57/100 vs 55/100) and 25.4% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medical Properties Trust, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities.

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?